SEC 13F Intelligence

Assenagon Asset Management S.A. / ELV

Assenagon Asset Management S.A.’s Elevance Health Inc Formerly Position

Does Assenagon Asset Management S.A. own Elevance Health Inc Formerly (ELV)? Yes — 299.4K shares worth $116M (+0.14% of its 13F portfolio) as of Q2 2026, up from 114.8K shares the prior filed quarter.

Position Value
$116M
Q2 2026
Shares
299.4K
% of Portfolio
+0.14%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q1 ’19: $25MQ1 ’19Q2 ’19: $31MQ3 ’19: $54MQ4 ’19: $4MQ1 ’20: $61MQ1 ’20Q2 ’20: $37MQ3 ’20: $5MQ4 ’20: $10MQ1 ’21: $35MQ1 ’21Q2 ’21: $31MQ3 ’21: $2MQ4 ’21: $3MQ1 ’22: $46MQ1 ’22Q2 ’22: $4MQ3 ’22: $66MQ4 ’22: $101MQ1 ’23: $37MQ1 ’23Q2 ’23: $52MQ3 ’23: $160MQ4 ’23: $147MQ1 ’24: $117MQ1 ’24Q2 ’24: $17MQ3 ’24: $135MQ4 ’24: $85MQ1 ’25: $50MQ1 ’25Q2 ’25: $148MQ3 ’25: $146MQ4 ’25: $186MQ1 ’26: $34MQ1 ’26Q2 ’26: $116Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026299.4K$116M+0.14%
Q1 2026114.8K$34M+0.05%
Q4 2025529.5K$186M+0.26%
Q3 2025452.5K$146M+0.20%
Q2 2025380.4K$148M+0.22%
Q1 2025113.8K$50M+0.08%
Q4 2024231.7K$85M+0.14%
Q3 2024260.1K$135M+0.25%
Q2 202431.8K$17M+0.04%
Q1 2024225.7K$117M+0.28%
Q4 2023311.5K$147M+0.39%
Q3 2023366.8K$160M+0.49%
Q2 2023117.3K$52M+0.18%
Q1 202380.7K$37M+0.13%
Q4 2022196.5K$101M+0.36%
Q3 2022145.1K$66M+0.25%
Q2 20228.1K$4M+0.01%
Q1 202293.3K$46M+0.13%
Q4 20217.1K$3M+0.01%
Q3 20214.7K$2M+0.01%
Q2 202181.4K$31M+0.11%
Q1 202196.2K$35M+0.14%
Q4 202031.1K$10M+0.04%
Q3 202016.9K$5M+0.03%
Q2 2020141.3K$37M+0.24%
Q1 2020269.3K$61M+0.49%
Q4 201911.7K$4M+0.02%
Q3 2019223.5K$54M+0.36%
Q2 2019111.0K$31M+0.24%
Q1 201988.8K$25M+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of ELV.